Clinical Trial Update: Calcineurin Activity in Renal Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating calcineurin activity in renal transplant recipients with rejection has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Rejection

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Renal Transplant Rejection | Phase 4 | Status: TERMINATED